Symbiotec Pharmalab IPO

Grey market premium: ₹185(+18.7%)· expected listing price ≈ ₹1173

As of 1 Sept, 1:05 pm IST · source ipowatch.in · unofficial, not exchange-sanctioned · indicative and may be inaccurate.

9 houses tracked: 4 positive · 3 cautious · 1 neutral · 0 negative · 1 unrated

Ratings as published by each house; links open the source. IPOSarthi does not rate IPOs.

• Symbiotech, Hy-Tech fly high on mkt debut; Skyways Air disappoints

  Business Standard · 1 Sept, 10:50 pm

• Symbiotech, Hy-Tech fly high on mkt debut; Skyways Air disappoints

  Business Standard · 1 Sept, 10:50 pm

• Symbiotec Pharmalab shares end over 11% higher after flat debut

  Rediff · 1 Sept, 4:52 pm

• Symbiotec Pharmalab shares list at par with IPO issue price on NSE

  Dailyhunt · 1 Sept, 3:53 pm

• Three IPOs, Three Different Debuts: What Symbiotec, Skyways Air Services And Hy-Tech Engineers Tell Investors

  outlookbusiness.com · 1 Sept, 1:29 pm

What is the GMP of Symbiotec Pharmalab IPO today?

As of 1 Sept, 1:05 pm IST, the grey market premium (GMP) of Symbiotec Pharmalab IPO is ₹185 per share, about +18.7% over the upper price band of ₹988, which points to an indicative listing price near ₹1173. GMP is an unofficial, off-exchange figure sourced from public trackers (ipowatch.in); it can change quickly and does not guarantee the listing price.

What is the lot size and minimum investment for Symbiotec Pharmalab IPO?

One lot of Symbiotec Pharmalab IPO is 15 shares. At the upper price band of ₹988, one lot costs ₹14,820, which is the minimum retail application. Retail investors can bid for up to 13 lots (₹1,92,660) within the ₹2 lakh retail cap. Small HNI (sNII) applications start at 14 lots (₹2,07,480) and big HNI (bNII) applications at 68 lots (₹10,07,760).

When is the Symbiotec Pharmalab IPO allotment and listing date?

Symbiotec Pharmalab IPO opened on 24 Aug 2026 and closed on 27 Aug 2026. The basis of allotment is expected on 28 Aug 2026, refunds / UPI unblocking on 31 Aug 2026, and the shares are expected to list on 1 Sep 2026 on BSE and NSE.

How many times is Symbiotec Pharmalab IPO subscribed?

As of 31 Aug, 9:10 am IST, Symbiotec Pharmalab IPO is subscribed 75.1x overall — QIB 181x, bNII 77.6x, sNII 77.6x, Retail 13.7x, Employee 16.3x. Figures come from exchange bid data via public trackers and update through the bidding window.

Should I apply for Symbiotec Pharmalab IPO?

IPOSarthi does not make recommendations — this page only lays out the data. The grey market is currently pricing the issue at ₹185 above the upper band (+18.7%). The book is 75.1x subscribed overall. 9 broker houses have published a view: 4 positive, 3 cautious, 1 neutral, 0 negative, 1 unrated. Read the red herring prospectus, weigh the company's financials and valuation against your own goals and risk appetite, and consult a SEBI-registered investment adviser before applying. GMP and subscription are indicative, not a forecast of listing gains.

• HD Fire Protect IPOUpcoming · opens 13 Oct 2026GMP ₹75
• Fusion CX IPOUpcoming · opens 14 Oct 2026GMP ₹25
• Bonfiglioli Transmissions IPOUpcoming · opens 15 Oct 2026GMP ₹175
• Sahajanand Medical IPOUpcoming · opens 15 Oct 2026GMP ₹40